Comparison of Fludarabine Versus Bendamustine as a Lymphodepleting Chemotherapy Prior to CAR-T for Large Cell Lymphoma

Fludarabine improved cancer response rates better than bendamustine, though bendamustine caused fewer severe immune side effects in CAR-T recipients.

What the study was

A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.